Owner Yale University

Inventors Egan, Marie, E.; Caplan, Michael, J.

Agent Davies Collison Cave

Pub. Number AU-B-2002356565

PCT Number PCT/US02/32801

PCT Pub. Number WO2003/049717

Priority 09/976,963 12.10.01 US; 10/200,607 22.07.02 US

Filing date 15 October 2002

Wipo publication date 23 June 2003

Acceptance publication date 12 March 2009

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/47 (2006.01) - Quinolines

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets